Literature DB >> 7916135

Pituitary adenylate cyclase activating peptide (PACAP) mRNA in the rat neocortex.

J D Mikkelsen1, J Hannibal, P J Larsen, J Fahrenkrug.   

Abstract

In agreement with previous studies, Northern blots revealed expression of pituitary adenylate cyclase-activating peptide (PACAP) mRNA in the rat cerebral cortex. In order to identify the cells expressing PACAP mRNA, semiquantitative in situ hybridization histochemistry was applied. A moderate concentration of PACAP mRNA transcripts was determined in the cingulate and frontal cortices, whereas lower concentrations were found in other cortical areas. In emulsion dipped sections, grains were detected over cell bodies in cortical layers II, III and IV. Grains were diffusely distributed over cells in the outer granular layer of the anterior cingulate and the retrosplenial areas. In the outer pyramidal cell layer a few neurons contained a large number of grains. These data show that PACAP mRNA is present in cells outside the hypothalamus and implies that PACAP could play a broader transmitter role in the CNS than earlier anticipated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916135     DOI: 10.1016/0304-3940(94)90620-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism.

Authors:  M Figiel; J Engele
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

2.  Identification of pituitary adenylate cyclase-activating polypeptide1-38-binding factor in human plasma, as ceruloplasmin.

Authors:  J W Tams; A H Johnsen; J Fahrenkrug
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

3.  Pituitary adenylate cyclase-activating peptide-immunoreactive nerve fibers in the cat eye.

Authors:  T Elsås; R Uddman; F Sundler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-09       Impact factor: 3.117

Review 4.  Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.

Authors:  Anne Luise Haulund Vollesen; Faisal Mohammad Amin; Messoud Ashina
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

5.  Altered calmodulin response to light in the suprachiasmatic nucleus of PAC1 receptor knockout mice revealed by proteomic analysis.

Authors:  Jan Fahrenkrug; Jens Hannibal; Bent Honoré; Henrik Vorum
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  High-resolution characterization of a PACAP-EGFP transgenic mouse model for mapping PACAP-expressing neurons.

Authors:  Michael C Condro; Anna Matynia; Nicholas N Foster; Yukio Ago; Abha K Rajbhandari; Christina Van; Bhavaani Jayaram; Sachin Parikh; Anna L Diep; Eileen Nguyen; Victor May; Hong-Wei Dong; James A Waschek
Journal:  J Comp Neurol       Date:  2016-06-03       Impact factor: 3.215

7.  Behavioral role of PACAP signaling reflects its selective distribution in glutamatergic and GABAergic neuronal subpopulations.

Authors:  Limei Zhang; Vito S Hernandez; Charles R Gerfen; Sunny Z Jiang; Lilian Zavala; Rafael A Barrio; Lee E Eiden
Journal:  Elife       Date:  2021-01-19       Impact factor: 8.140

Review 8.  PACAP38 and PAC1 receptor blockade: a new target for headache?

Authors:  Eloisa Rubio-Beltrán; Edvige Correnti; Marie Deen; Katharina Kamm; Tim Kelderman; Laura Papetti; Simone Vigneri; Antoinette MaassenVanDenBrink; Lars Edvinsson
Journal:  J Headache Pain       Date:  2018-08-07       Impact factor: 7.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.